| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
119,920,000 |
| Market
Cap: |
2.48(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$14.96 - $32.96 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Denali Therapeutics is a biopharmaceutical company that discovers and develops therapeutics to defeat neurodegenerative diseases. Co.'s clinical-stage programs are: leucine-rich repeat kinase 2 inhibitor program to address Parkinson's disease; enzyme transport vehicle :IDS program, its lead brain-penetrant enzyme replacement therapy, enabled by its enzyme transport vehicle, which is designed to restore iduronate 2-sulfatase, and reduce glycosaminoglycans, both peripherally and in the brain, in patients with mucopolysaccharidosis II; and eukaryotic initiation factor 2 B activator program to address diseases such as amyotrophic lateral sclerosis and frontotemporal dementia.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
97,506 |
194,997 |
252,199 |
526,275 |
| Total Sell Value |
$1,994,341 |
$3,816,456 |
$5,294,638 |
$13,483,252 |
| Total People Sold |
2 |
5 |
5 |
6 |
| Total Sell Transactions |
4 |
19 |
38 |
76 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Schuth Alexander O. |
COO and Secretary |
• – – |
2019-03-13 |
4 |
AS |
$23.60 |
$60,387 |
I/I |
(2,512) |
655,089 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-03-12 |
4 |
AS |
$22.40 |
$56,291 |
I/I |
(2,513) |
657,601 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-03-11 |
4 |
AS |
$21.20 |
$52,635 |
I/I |
(2,475) |
660,114 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-03-05 |
4 |
AS |
$21.96 |
$128,730 |
D/D |
(5,862) |
0 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-03-05 |
4 |
OE |
$5.28 |
$30,951 |
D/D |
5,862 |
5,862 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2019-03-05 |
4 |
AS |
$21.97 |
$134,918 |
I/I |
(6,141) |
2,615,971 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-03-04 |
4 |
AS |
$21.87 |
$129,776 |
D/D |
(5,863) |
0 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-03-04 |
4 |
OE |
$5.28 |
$30,957 |
D/D |
5,863 |
5,863 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2019-03-04 |
4 |
AS |
$21.87 |
$135,958 |
I/I |
(6,142) |
2,622,112 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-03-01 |
4 |
AS |
$22.17 |
$129,495 |
D/D |
(5,775) |
0 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-03-01 |
4 |
OE |
$5.28 |
$30,492 |
D/D |
5,775 |
5,775 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2019-03-01 |
4 |
AS |
$22.19 |
$135,726 |
I/I |
(6,050) |
2,628,254 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-02-12 |
4 |
AS |
$19.73 |
$50,192 |
I/I |
(2,500) |
662,589 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-02-11 |
4 |
AS |
$18.74 |
$47,622 |
I/I |
(2,500) |
665,089 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-02-08 |
4 |
AS |
$18.11 |
$45,275 |
I/I |
(2,500) |
667,589 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2019-02-05 |
4 |
AS |
$18.83 |
$154,971 |
I/I |
(8,230) |
2,634,304 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-02-05 |
4 |
AS |
$18.83 |
$147,928 |
D/D |
(7,856) |
0 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-02-05 |
4 |
OE |
$5.28 |
$41,480 |
D/D |
7,856 |
7,856 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2019-02-04 |
4 |
AS |
$18.49 |
$75,496 |
I/I |
(4,054) |
2,642,534 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-02-04 |
4 |
AS |
$18.49 |
$72,015 |
D/D |
(3,869) |
0 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-02-04 |
4 |
OE |
$5.28 |
$20,428 |
D/D |
3,869 |
3,869 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2019-02-01 |
4 |
AS |
$18.65 |
$112,833 |
I/I |
(6,050) |
2,646,588 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-02-01 |
4 |
AS |
$18.64 |
$107,646 |
D/D |
(5,775) |
0 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-02-01 |
4 |
OE |
$5.28 |
$30,492 |
D/D |
5,775 |
5,775 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-01-11 |
4 |
AS |
$20.80 |
$52,000 |
I/I |
(2,500) |
670,089 |
|
- |
|
426 Records found
|
|
Page 15 of 18 |
|
|
0.29 (1.42%) 
